/WXIBF

WXIBF Stock - WuXi Biologics (Cayman) Inc.

Q: What is the analyst price target for WXIBF?

Analyst price target information is not currently available for WXIBF.

Q: What is WXIBF's market cap?

Market capitalization information is not currently available for WXIBF.

Healthcare|Biotechnology|OTC

$4.29+1.59%

+$0.07 (+1.59%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $4.72

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for WXIBF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.50

52W High$5.61

52W Low$2.17

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$18.68B	$17.03B	$15.27B	$10.29B	$5.61B
Gross Profit	$7.65B	$6.83B	$6.72B	$4.83B	$2.53B
Gross Margin	41.0%	40.1%	44.0%	46.9%	45.1%
Operating Income	$4.97B	$4.45B	$4.34B	$3.19B	$1.50B
Net Income	$3.36B	$3.40B	$4.42B	$3.39B	$1.69B
Net Margin	18.0%	20.0%	29.0%	32.9%	30.1%
EPS	$0.82	$0.81	$1.06	$0.81	$0.43

Company Overview

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Visit Website

Earnings History & Surprises

WXIBF

Beat Rate

40%

Last 10 quarters

Avg Surprise

-5.6%

EPS vs Estimate

Beats / Misses

4/6

Last 12 quarters

Latest EPS

$0.08

Q3 2025

EPS Surprise History

Q4 21

-0.6%

$0.05vs$0.06

Q3 22

-78.4%

$0.09vs$0.40

Q1 23

+14.5%

$0.06vs$0.06

Q2 23

-5.1%

$0.07vs$0.08

Q1 24

+4.5%

$0.04vs$0.04

Q3 24

-14.1%

$0.05vs$0.06

Q1 25

-0.1%

$0.06vs$0.06

Q3 25

+24.1%

$0.08vs$0.06

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Mar 23, 2026	—	—	—	—
Q3 2025	Aug 19, 2025	$0.06	$0.08	+24.1%	✓ BEAT
Q1 2025	Mar 25, 2025	$0.06	$0.06	-0.1%	✗ MISS
Q3 2024	Aug 21, 2024	$0.06	$0.05	-14.1%	✗ MISS
Q1 2024	Mar 26, 2024	$0.04	$0.04	+4.5%	✓ BEAT
Q2 2023	Jun 30, 2023	$0.08	$0.07	-5.1%	✗ MISS
Q1 2023	Mar 22, 2023	$0.06	$0.06	+14.5%	✓ BEAT
Q3 2022	Aug 17, 2022	$0.40	$0.09	-78.4%	✗ MISS
Q4 2021	Dec 31, 2021	$0.06	$0.05	-0.6%	✗ MISS
Q3 2021	Aug 23, 2021	$0.06	$0.06	+1.8%	✓ BEAT
Q1 2021	Mar 23, 2021	$0.04	$0.03	-2.9%	✗ MISS
Q3 2020	Aug 17, 2020	—	$0.03	—	—
Q1 2020	Mar 26, 2020	—	$0.02	—	—
Q3 2019	Aug 19, 2019	—	$0.02	—	—
Q1 2019	Mar 18, 2019	—	$0.01	—	—
Q3 2018	Aug 20, 2018	—	$0.01	—	—
Q1 2018	Mar 19, 2018	—	$0.01	—	—
Q3 2017	Sep 20, 2017	—	$0.00	—	—
Q2 2017	May 31, 2017	—	$0.00	—	—
Q2 2016	Jun 30, 2016	—	$0.00	—	—

Frequently Asked Questions about WXIBF

What is WXIBF's current stock price?

WuXi Biologics (Cayman) Inc. (WXIBF) is currently trading at $4.29 per share. The stock has moved +1.59% today.

What is the analyst price target for WXIBF?

No analyst price targets are currently available for this stock.

What sector is WuXi Biologics (Cayman) Inc. in?

WuXi Biologics (Cayman) Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is WXIBF's market cap?

WuXi Biologics (Cayman) Inc. has a market capitalization of $17.44 billion, making it a large-cap company.

Does WXIBF pay dividends?

No, WuXi Biologics (Cayman) Inc. does not currently pay a dividend to shareholders.